D'Angelo Lauren — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

D'Angelo Lauren has filed 1 SEC Form 4 filing across 1 company in the last 90 days — buying. Lifetime open-market purchases: $20K.

Profile

Lauren D'Angelo is the Chief Operating Officer of Alpha Cognition Inc., a biopharmaceutical company focused on developing treatments for neurodegenerative diseases and the commercial development program for ZUNVEYL. The most recent SEC filing (CIK 0002032983) dated 2026-01-14 lists D'Angelo as COO with no reported purchases or sales and indicates a single filing in this context.

Board memberships

• Alpha Cognition Inc.

Awards & honors

• Oversees operations for Alpha Cognition's commercialization program for ZUNVEYL
• Responsible for manufacturing operations and organizational efficiency

Recent Transactions

Companies — Last 90 Days

• Alpha Cognition Inc. (ACOG) — 1 filings, last 2026-05-19

Frequently Asked Questions

Who is D'Angelo Lauren?

Lauren D'Angelo is the Chief Operating Officer of Alpha Cognition Inc., a biopharmaceutical company focused on developing treatments for neurodegenerative diseases and the commercial development program for ZUNVEYL. The most recent SEC filing (CIK 0002032983) dated 2026-01-14 lists D'Angelo as COO with no reported purchases or sales and indicates a single filing in this context…

How many SEC Form 4 filings has D'Angelo Lauren submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has D'Angelo Lauren been buying or selling stock?

Recorded transactions: 1 open-market purchases ($20K) and 0 open-market sales () across all tracked filings.

Where can I see all of D'Angelo Lauren's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week